Company: ANY
Filing Date: 2025-01-03
Form Type: 424B5
Source: 0001062993-25-000228
Chunk: 0

Company: Sphere 3D Corp.
Filing Date: 2025-01-03
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)

Registration No. 333-269663

PROSPECTUS SUPPLEMENT

(To Prospectus Dated October 10, 2024)

<div align='center'>SPHERE 3D CORP.

$8,000,000

Common Shares</div>

This prospectus supplement and the accompanying prospectus relate to the issuance and sale of up to $8,000,000 of our common shares, no par value ("common shares"), from time to time through our sales agent, A.G.P./Alliance Global Partners ("A.G.P." or the "Sales Agent"). These sales, if any, will be made pursuant to the terms of the Sales Agreement (the "Sales Agreement"), by and between the Company and the Sales Agent.

Sales of our common shares under this prospectus supplement, if any, may be made by any method deemed to be an "at the market offering" as defined in Rule 415 under the Securities Act of 1933, as amended (the "Securities Act").

The Sales Agent is not required to sell any specific number or dollar amount of securities. Instead, the Sales Agent has agreed to use its commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between the Sales Agent and the Company. There is no arrangement for funds to be received in any escrow, trust or similar arrangement. The Sales Agent will be entitled to compensation under the terms of the Sales Agreement at a commission rate equal to 3% of the gross sales price from sales of common shares under this offering. We will use the net proceeds from any sales under this prospectus supplement as described under "Use of Proceeds." The amount of proceeds we receive from sales of our common shares, if any, will depend on the number of shares actually sold and the offering price of such shares.

In connection with the sale of common shares on our behalf, the Sales Agent will be deemed to be an underwriter within the meaning of the Securities Act, and its compensation as the sales agent will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to the Sales Agent with respect to certain liabilities, including liabilities under the Securities Act.

Our common shares are listed on the Nasdaq Capital Market under the symbol "ANY." The last reported sale price of our common shares on the Nasdaq Capital Market on January 2, 2025, was $1.01 per share.

As of the date of this supplement